187 related articles for article (PubMed ID: 31357190)
1. The experimental dose ranges influence the LET
Rørvik E; Thörnqvist S; Ytre-Hauge KS
Phys Med Biol; 2019 Sep; 64(19):195001. PubMed ID: 31357190
[TBL] [Abstract][Full Text] [Related]
2. The incorporation of the concept of minimum RBE (RbEmin) into the linear-quadratic model and the potential for improved radiobiological analysis of high-LET treatments.
Carabe-Fernandez A; Dale RG; Jones B
Int J Radiat Biol; 2007 Jan; 83(1):27-39. PubMed ID: 17357437
[TBL] [Abstract][Full Text] [Related]
3. Investigating the impact of alpha/beta and LET
Mara E; Clausen M; Khachonkham S; Deycmar S; Pessy C; Dörr W; Kuess P; Georg D; Gruber S
Med Phys; 2020 Aug; 47(8):3691-3702. PubMed ID: 32347564
[TBL] [Abstract][Full Text] [Related]
4. Systematics of relative biological effectiveness measurements for proton radiation along the spread out Bragg peak: experimental validation of the local effect model.
Grün R; Friedrich T; Krämer M; Scholz M
Phys Med Biol; 2017 Feb; 62(3):890-908. PubMed ID: 28072575
[TBL] [Abstract][Full Text] [Related]
5. Dose averaged linear energy transfer optimization for large sacral chordomas in carbon ion therapy.
Schafasand M; Resch AF; Nachankar A; Góra J; Martino G; Traneus E; Glimelius L; Georg D; Fossati P; Carlino A; Stock M
Med Phys; 2024 Jun; 51(6):3950-3960. PubMed ID: 38696546
[TBL] [Abstract][Full Text] [Related]
6. Is the dose-averaged LET a reliable predictor for the relative biological effectiveness?
Grün R; Friedrich T; Traneus E; Scholz M
Med Phys; 2019 Feb; 46(2):1064-1074. PubMed ID: 30565705
[TBL] [Abstract][Full Text] [Related]
7. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
[TBL] [Abstract][Full Text] [Related]
8. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
[TBL] [Abstract][Full Text] [Related]
9. A phenomenological biological dose model for proton therapy based on linear energy transfer spectra.
Rørvik E; Thörnqvist S; Stokkevåg CH; Dahle TJ; Fjaera LF; Ytre-Hauge KS
Med Phys; 2017 Jun; 44(6):2586-2594. PubMed ID: 28295379
[TBL] [Abstract][Full Text] [Related]
10. Exploration and application of phenomenological RBE models for proton therapy.
Rørvik E; Fjæra LF; Dahle TJ; Dale JE; Engeseth GM; Stokkevåg CH; Thörnqvist S; Ytre-Hauge KS
Phys Med Biol; 2018 Sep; 63(18):185013. PubMed ID: 30102240
[TBL] [Abstract][Full Text] [Related]
11. A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.
McNamara AL; Schuemann J; Paganetti H
Phys Med Biol; 2015 Nov; 60(21):8399-416. PubMed ID: 26459756
[TBL] [Abstract][Full Text] [Related]
12. Modeling RBE with other quantities than LET significantly improves prediction of in vitro cell survival for proton therapy.
Kalholm F; Grzanka L; Toma-Dasu I; Bassler N
Med Phys; 2023 Jan; 50(1):651-659. PubMed ID: 36321465
[TBL] [Abstract][Full Text] [Related]
13. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of dose-averaged linear energy transfer (LET
Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
[TBL] [Abstract][Full Text] [Related]
15. Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.
Pedersen J; Petersen JBB; Stokkevåg CH; Ytre-Hauge KS; Flampouri S; Li Z; Mendenhall N; Muren LP
Acta Oncol; 2017 Nov; 56(11):1413-1419. PubMed ID: 29037095
[TBL] [Abstract][Full Text] [Related]
16. Clinical radiobiology of proton therapy: modeling of RBE.
Jones B
Acta Oncol; 2017 Nov; 56(11):1374-1378. PubMed ID: 28820311
[TBL] [Abstract][Full Text] [Related]
17. Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.
Paganetti H
Phys Med Biol; 2014 Nov; 59(22):R419-72. PubMed ID: 25361443
[TBL] [Abstract][Full Text] [Related]
18. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
19. Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer.
Fjæra LF; Li Z; Ytre-Hauge KS; Muren LP; Indelicato DJ; Lassen-Ramshad Y; Engeseth GM; Brydøy M; Mairani A; Flampouri S; Dahl O; Stokkevåg CH
Acta Oncol; 2017 Jun; 56(6):763-768. PubMed ID: 28423966
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the track- and dose-averaged LET and LET spectra in proton therapy using the geant4 Monte Carlo code.
Guan F; Peeler C; Bronk L; Geng C; Taleei R; Randeniya S; Ge S; Mirkovic D; Grosshans D; Mohan R; Titt U
Med Phys; 2015 Nov; 42(11):6234-47. PubMed ID: 26520716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
